US Stock Futures Tumble Ahead Of Wholesale Inventories Data - Ocular Therapeutix (NASDAQ:OCUL)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Pre-open moversUS stock futures traded lower in early pre-market trade. The NFIB Small Business Optimism Index for February will be released at 9:00 a.m. ET, while wholesale inventories data for January will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average dropped 123 points to 17,847.00, while the Standard & Poor's 500 index futures fell 15 points to 2,062.70. Futures for the Nasdaq 100 index declined 31.75 points to 4,381.75.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

A Peek Into Global Markets European markets were lower today, with the Spanish Ibex Index falling 1.23%, STOXX Europe 600 Index declining 0.18% and German DAX 30 index dropping 0.66%. French CAC 40 Index slipped 0.60% and London's FTSE 100 Index fell 0.61%.In Asian markets, Japan's Nikkei Stock Average fell 0.67%, Hong Kong's Hang Seng Index dropped 0.94%, China's Shanghai Composite Index slipped 0.49% and India's BSE Sensex fell 0.47%.Broker RecommendationAnalysts at Janney Capital upgraded

Urban Outfitters Inc. (NASDAQ: URBN) from Neutral to Buy and raised the price target from $37.00 to $48.00. Urban Outfitters shares rose 1.59% to close at $39.51 yesterday.Breaking news

Ocular Therapeutix (NASDAQ: OCUL) today announced positive topline data from the first of two Phase 3 clinical trials evaluating the safety and efficacy of its lead product candidate, OTX-DP (Sustained Release Dexamethasone), for the treatment of ocular inflammation and pain following cataract surgery. To read the full news, click here.
Trimble (NASDAQ: TRMB) announced today that it has acquired privately-held Fifth Element, a leader in forestry enterprise and mobile software solutions for logistics and harvest operations. To read the full news, click here.
Applied Genetic Technologies Corporation (NASDAQ: AGTC) today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to conduct a Phase I/II clinical trial of the company's gene therapy product candidate for the treatment of X-linked retinoschisis (XLRS). To read the full news, click here.
Urban Outfitters Inc. (NASDAQ: URBN) reported upbeat earnings for the fourth quarter on Monday. To read the full news, click here.